Preface
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
i-i
Author(s):
Zhou Xing
Consideration of Cytokines as Therapeutics Agents or Targets
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
599-611
Author(s):
Zhou Xing and Jun Wang
Gene Vectors for Cytokine Expression In Vivo
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
613-632
Author(s):
M. M. Hitt and J. Gauldie
Anti-inflammatory Cytokines and Cytokine Antagonists
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
633-649
Author(s):
Theodore J. Standiford
Therapeutic Use of Chemokines
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
651-663
Author(s):
Cory M. Hogaboam, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew L. Steinhauser, Kate Blease, Nicholas W. Lukacs and Steven L. Kunkel
Cytokine Therapeutics for Infectious Diseases
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
665-680
Author(s):
F. H. Rodriguez, S. Nelson and J. K. Kolls
Cytokine Therapy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
681-699
Author(s):
M. Tagawa
Quantitative Structure - Activity Relationship (QSAR) Studies on Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
375-388
Author(s):
Dimitra Hadjipavlou-Litina
Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
417-439
Author(s):
Maralea Gourley and John S. Williamson
Genetically Engineered Monoclonal Antibodies for Direct Anti-Neoplastic Treatment and Cancer Cell Specific Delivery of Chemotherapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
261-276
Author(s):
Bela Bodey, Bela Bodey Jr., Stuart E. Siegel and Hans E. Kaiser